Acer Therapeutics
Cambridge, US · Founded 2013 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
CL
Cynthia LavoieDirector
HS
Harry S. PalminExecutive Officer, Director, Promoter
CS
Christopher SchellingExecutive Officer, Director, Promoter
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$15.7MraisedOct 2017 · 10 investors · PharmaceuticalsRule 506(b)
▶$15.7MraisedOct 2017 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert SteinerExecutive Officer
- Christopher SchellingExecutive Officer, Director
- Harry S. PalminExecutive Officer
- John DunnDirector
- Hubert BirnerDirector
- Luc MarengereDirector
- Stephen AselageDirector
- Offering amount
- $15.7M
- Amount sold
- $15.7M
- Sales commissions
- $1.1M
- Finders' fees
- $67.5K
- Proceeds to insiders
- $948K
- Placement agents
- Piper Jaffray & Co.
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$3.1MraisedApr 2017 · 4 investors · PharmaceuticalsRule 506(b)
▶$3.1MraisedApr 2017 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John DunnDirector
- Christopher SchellingExecutive Officer, Director, Promoter
- Luc MarengereDirector
- Stephen AselageDirector
- Harry PalminPromoter
- Offering amount
- $5.5M
- Amount sold
- $3.1M
- Proceeds to insiders
- $419K
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$8.1MraisedMay 2016 · 6 investors · PharmaceuticalsRule 506(b)
▶$8.1MraisedMay 2016 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John DunnDirector
- Harry S. PalminPromoter
- Christopher SchellingExecutive Officer, Director, Promoter
- Stephen AselageDirector
- Cynthia LavoieDirector
- Luc MarengereDirector
- Offering amount
- $8.1M
- Amount sold
- $8.1M
- Proceeds to insiders
- $740K
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$2.1MraisedApr 2015 · 2 investors · PharmaceuticalsRule 506(b)
▶$2.1MraisedApr 2015 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Cynthia LavoieDirector
- Harry S. PalminExecutive Officer, Director, Promoter
- Christopher SchellingExecutive Officer, Director, Promoter
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- Proceeds to insiders
- $290K
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.